Portfolio company
Sansanima Ltd
United Kingdom
Raised
Undisclosed
Latest stage
Seed
Rounds recorded
2 · 2 undisclosed
Backed by
3 investors
Sectors
About
Sansanima Ltd develops cell-based assay platforms for manufacturers to replace animal testing in the safety and potency validation of clostridial neurotoxin-based biologics.
SourceFunding history · 2
Similar companies
Cytochroma
This company manufactures genetically diverse stem cell-derived mini-organs to provide animal-free drug safety and efficacy testing for pharmaceutical and biotechnology organisations.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
Sensible Bio
Sensible Bio develops cell-based biomanufacturing platforms to produce high-quality mRNA for healthcare companies creating next-generation vaccines and therapeutics.
Hesperos
This company develops multi-organ microchips for pharmaceutical researchers to test drug efficacy and safety without using animals.
BioHive
BioHive provides skin organoids derived from stem cells to pharmaceutical and dermocosmetic companies for toxicity and efficacy testing.
Clyde Biosciences
This company provides cardiac safety and efficacy testing services for pharmaceutical and biotechnology organisations using its proprietary cell-based assay platform.
Invitrolize
This company develops in vitro lung models to identify respiratory hazards for pharmaceutical, cosmetic, chemical and consumer goods organisations.
